Metronidazol B Infomed Fluids

Metronidazole, the active ingredient in Metronidazol B Infomed Fluids, is a nitroimidazole antibiotic presented as an injectable solution for intravenous use. It is employed to treat anaerobic bacterial infections and certain protozoal diseases in both adult and pediatric patients, including severe intra‑abdominal infections and bacterial vaginosis.

GNH USA supplies Metronidazol B Infomed Fluids as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for cross‑border distribution.

Metronidazole is used to treat infections caused by anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: eradicates susceptible anaerobes, reducing infection severity. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, aiding clinical recovery. - Bacterial vaginosis: restores normal vaginal flora by targeting anaerobic pathogens. - Amoebiasis: eliminates Entamoeba histolytica trophozoites, preventing tissue invasion. - Giardiasis: clears Giardia lamblia trophozoites, relieving gastrointestinal symptoms.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient alteration of taste perception. - Headache: occasional mild to moderate headache. - Diarrhea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events, especially with high doses. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis or angioedema. - Stevens‑Johnson syndrome: severe skin and mucosal reactions.

Metronidazole requires careful consideration of patient factors and handling. - Renal impairment: adjust therapy based on renal function. - Hepatic disease: monitor liver enzymes during treatment. - Alcohol consumption: avoid due to disulfiram‑like reaction. - Pregnancy: use only if benefits outweigh potential risks. - Concurrent use with alcohol‑containing solutions: avoid to prevent adverse reactions. - Store at ambient temperature: keep in original container, protect from light and moisture.

Metronidazole can interact with several medicines, requiring vigilance.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Warfarin: may increase anticoagulant effect, raising bleeding risk. - Lithium: may elevate lithium concentrations, risking toxicity. - Cimetidine: may increase metronidazole plasma levels.

Moderate Interactions (Monitor Closely): - Phenobarbital: may reduce metronidazole concentrations. - Carbamazepine: may lower efficacy of metronidazole. - Phenytoin: may decrease metronidazole plasma levels.